Roel Bulthuis Overview

  • Primary Position
  • Managing Partner...

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 3

  • Med. Deal Size

  • Med. Valuation

Roel Bulthuis General Information

Biography

Mr. Roel Bulthuis serves as Managing Partner & Head of Investments at Syncona. He served as Board Member at Comet Therapeutics. He serves as a Board Member at Draupnir Bio & tincture. He served as a Board Member at VarmX. He served as a Board Member at Canbex Therapeutics and Calypso Biotech. He served as a Board Member at Salvia BioElectronics. He also served as a Venture Advisor at The Founders Club. He served as Managing Director at Inkef Capital. He served as a Board Member at QurAlis and Scenic Biotech. He also founded and served as Senior Vice President and Managing Director of Merck Ventures. He joined the biopharmaceutical division of Merck KGaA, Darmstadt, Germany in 2006 and started MS Ventures in 2009. Previously, he was a Director in the Biotech Investment Banking Team at Fortis Bank, where he was responsible for the origination and execution of a wide range of financing and strategic transactions in the biotech sector based out of Amsterdam and New York. Before joining Fortis Bank, he worked at Devgen NV in Gent, Belgium, as a business analyst. He holds an MSc. in Biopharmaceutical Sciences from Leiden University, the Netherlands, and an MBA in Finance from the Helsinki School of Economics, Finland.

Contact Information

Primary Position
Managing Partner & Head of Investments, Syncona
Education
Hanken School of Economics in Helsinki, MBA (Master of Business Administration)
Leiden University, MS (Master of Science)
Gender
Male
Email
r.
Phone
+44 020
Address
  • 2nd Floor
  • 8 Bloomsbury Street
  • London WC1B 3SR
  • England, United Kingdom
+44 020

Roel Bulthuis Positions (1)

Firm name Firm type Title Location Industry Since
Syncona Investor Managing Partner & Head of Investments London, United Kingdom Venture Capital

Roel Bulthuis Board Seats (3)

Company Industry Ownership Status Financing Status Location Since
Draupnir Bio Drug Discovery Privately Held (backing) Venture Capital-Backed Copenhagen, Denmark
iOnctura Drug Discovery Privately Held (backing) Venture Capital-Backed Genève, Switzerland
NMD Pharma Biotechnology Privately Held (backing) Venture Capital-Backed Aarhus N, Denmark

Roel Bulthuis Lead Partner on Deals (22)

Roel Bulthuis has been the lead partner on 22 deals. Their latest deal was with iOnctura, a drug discovery company. The deal was made for on 20-Jun-2024.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
iOnctura 20-Jun-2024 Later Stage VC (Series B) Completed Drug Discovery Genève, Switzerland
VarmX 25-May-2023 Completed Drug Discovery Leiden, Netherlands
QurAlis 09-Mar-2023 Completed Biotechnology Cambridge, MA
Scenic Biotech 10-Mar-2022 Completed Drug Discovery Amsterdam, Netherlands
NMD Pharma 15-Feb-2022 Completed Biotechnology Aarhus N, Denmark
InteRNA Technologies 09-Feb-2021 Completed Drug Discovery Utrecht, Netherlands
Salvia BioElectronics 22-Sep-2020 Completed Therapeutic Devices Eindhoven, Netherlands
VarmX 03-Jul-2020 Completed Drug Discovery Leiden, Netherlands
QurAlis 13-May-2020 Early Stage VC (Series A1) Completed Biotechnology Cambridge, MA
Draupnir Bio 01-Oct-2019 Early Stage VC (Series A) Completed Drug Discovery Copenhagen, Denmark

Roel Bulthuis Network (292)

Board Members (138)

Name Company Representing Location From
Andrew McLean MD Scenic Biotech Oxford Science Enterprises Amsterdam, Netherlands
Stéphane Verdood Scenic Biotech Vesalius Biocapital Partners Amsterdam, Netherlands
F-Star Therapeutics Self Cambridge, United Kingdom
QurAlis Sanofi Ventures Cambridge, MA
NMD Pharma Roche Venture Fund Aarhus N, Denmark

Portfolio Executives (143)

Name Company Role Deal date Location
David Seeberger iOnctura Chief Financial Officer 20-Jun-2024 Genève, Switzerland
Michael Lahn iOnctura Chief Medical Officer 20-Jun-2024 Genève, Switzerland
iOnctura Co-Founder, CSO & Board Member 20-Jun-2024 Genève, Switzerland
iOnctura Co-Founder, Chief Executive Officer & Board Member 20-Jun-2024 Genève, Switzerland
iOnctura Member of Scientific Advisory Board 20-Jun-2024 Genève, Switzerland

Fund Team Members (11)

Name Investor Fund Fund Location
Nilesh Kumar Ph.D M Ventures Merck Serono Entrepreneur Partnership Program Amsterdam, Netherlands
Nilesh Kumar Ph.D M Ventures Merck Serono Israel BioIncubator Fund Amsterdam, Netherlands
M Ventures Amsterdam, Netherlands
M Ventures Amsterdam, Netherlands
M Ventures Amsterdam, Netherlands

Roel Bulthuis Affiliated Funds (4)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
Merck Serono Entrepreneur Partnership Program M Ventures Venture - General Closed 2013
Inkef Fund Inkef Venture Capital - Early Stage Closed 2007
Merck Serono Israel BioIncubator Fund M Ventures Venture Capital - Early Stage Closed 2011
M Ventures Healthcare M Ventures Venture - General Evergreen

Roel Bulthuis FAQs

  • Who is Roel Bulthuis?

    Mr. Roel Bulthuis serves as Managing Partner & Head of Investments at Syncona.

  • How much does Roel Bulthuis typically invest?

    Roel Bulthuis's median deal size is .

  • What is Roel Bulthuis’s main position?

    Roel Bulthuis’s primary position is Managing Partner & Head of Investments.

  • What are the contact details for Roel Bulthuis?

    Roel Bulthuis’s email address is r. and his phone number is +44 020 .

  • How many active board seats does Roel Bulthuis hold?

    Roel Bulthuis holds 3 board seats including Draupnir Bio, iOnctura, and NMD Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »